Cargando…
Risk of Respiratory Syncytial Virus Hospitalization in the First and Second Years of Life in Pediatric Patients with Congenital Heart Disease
Autores principales: | Friedman, Deborah, Wong, Pierre C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514211/ https://www.ncbi.nlm.nih.gov/pubmed/28536747 http://dx.doi.org/10.1007/s00246-017-1634-5 |
Ejemplares similares
-
Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses
por: Friedman, Deborah, et al.
Publicado: (2017) -
The Logistics and Coordination of Respiratory Syncytial Virus Immunoprophylaxis Use Among US Pediatric Specialists
por: Wong, Pierre C., et al.
Publicado: (2016) -
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
por: Wang, Daniel Y., et al.
Publicado: (2017) -
Respiratory syncytial virus prevention in children with congenital heart disease: who and how?
por: Kim, Nam Kyun, et al.
Publicado: (2011) -
Respiratory Syncytial Virus and Other Pediatric Respiratory Virus Infections
por: L., G.
Publicado: (1998)